Randomized Phase II Study of Two Schedules of Carboplatin and Gemcitabine for Stage IIIB and IV Advanced Non-Small Cell Lung Cancer (JACCRO LC-01 Study)-Reference-Cited by-同舟云学术

Randomized Phase II Study of Two Schedules of Carboplatin and Gemcitabine for Stage IIIB and IV Advanced Non-Small Cell Lung Cancer (JACCRO LC-01 Study)

Published:2011 Issue:4 Volume:57 Page:357-362
ISSN:1421-9794
Container-title:Chemotherapy
language:en
Short-container-title:Chemotherapy

Author:

Imamura Fumio,Nishio Makoto,Noro Rintaro,Tsuboi Masahiro,Ikeda Norihiko,Inoue Akira,Ohsaki Yoshinobu,Kimura Yukio,Nishino Kazumi,Uchida Junji,Horai Takeshi

Publisher

S. Karger AG

Subject

Infectious Diseases,Pharmacology (medical),Drug Discovery,Pharmacology,Oncology,General Medicine

Reference22 articles.

1. Meta-Analysis of Randomized Clinical Trials Comparing Cisplatin to Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

2. Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

3. Cytotoxicity of Cisplatin and Carboplatin Used Alone and in Combination with the Other Anticancer Drugs in the Mouse Embryo C3H10T½ Cell Line

4. Third-Generation Chemotherapy Agents in the Treatment of Advanced Non-small Cell Lung Cancer: A Meta-Analysis

5. Correlative studies of a phase I trial of combination anti-vascular endothelial growth factor (VEGF) therapy with sorafenib and bevacizumab

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancer mutations modulate the severity of chemotherapy-induced myelosuppression;Life Science Alliance;2024-01-16

2. The association of four genetic variants with myelosuppression in gemcitabine‐treated Japanese is not evident in gemcitabine/carboplatin‐treated Swedes;Basic & Clinical Pharmacology & Toxicology;2022-02-14

3. JMJD1C knockdown affects myeloid cell lines proliferation, viability, and gemcitabine/carboplatin-sensitivity;Pharmacogenetics and Genomics;2020-10-16

4. Genetic association of gemcitabine/carboplatin-induced leukopenia and neutropenia in non-small cell lung cancer patients using whole-exome sequencing;Lung Cancer;2020-09

5. Whole-genome sequencing and gene network modules predict gemcitabine/carboplatin-induced myelosuppression in non-small cell lung cancer patients;npj Systems Biology and Applications;2020-08-24